Nina Capital Holdings Inc

Nina Capital Holdings (10% Owner) buys 25,000 shares of PETS at $1.75; stock down -60.4% from 52-week high, insider's 5 prior PETS trades yielded 0 of 5 gains at 90-day mark.

Nina Capital Holdings purchased 25,000 shares of PetMed Express at $1.75, bringing its total stake to 2,600,000 shares. However, the stock has declined -25.0% in the past 30 days and -31.3% over 90 days, trading at $1.71 (currently -60.4% from its 52-week high of $4.32). The company's fundamentals are deteriorating: annual revenue growth was -21.1% and the company posted a net loss of $10,553,000 on quarterly revenue of $40,660,000, with full-year results also negative. Notably, this is the insider's sixth buy at PETS, yet the prior five purchases at this ticker all produced losses at the 90-day mark (0 of 5 well-timed), and the insider's broader cross-ticker track record shows a 90-day win rate of only 7.69% with an average 90-day return of -15.0%. The pattern of repeated purchases into a declining stock with deteriorating fundamentals and a history of failed buy timing at this specific ticker suggests limited insight into inflection points.

10% Owner NINA CAPITAL HOLDINGS INC. bought 25,000 shares of PETS at $3.50 (2025-07-21); stock now $3.51, down 46.8% from 52-week high.

NINA CAPITAL HOLDINGS INC., a 10% shareholder, purchased 25,000 shares at $3.50 on 2025-07-21, increasing holdings from 2,550,000 to 2,575,000 shares. This continues a pattern of repeated open-market purchases: five prior buys at PETS occurred between 2025-03-03 and 2025-06-03, with measurable 90-day outcomes on three of those trades showing 0 of 3 well-timed (returns of -11.9%, -3.6%, and -14.4%). The insider's broader cross-ticker track record shows 12 prior open-market buys with an average 90-day return of -12.3% and a 10.00% win rate. Fundamentally, PetMed Express reported quarterly revenue of $52,984,000.00 and a loss of $-707,000.00, with the company unprofitable over its most recent full fiscal year; the stock trades at a P/E of 175.50 and is currently 46.8% below its 52-week high. The repeated buying activity from a significant shareholder in a loss-making company with weak recent timing outcomes presents a mixed signal: while insider ownership concentration may suggest committed belief, the track record of negative outcomes on prior purchases at this ticker and the negative win rate on cross-ticker buys warrant careful attention to execution and market conditions.

10% Owner NINA CAPITAL HOLDINGS purchases 25,000 shares of PETS at $3.94; stock -40.3% from 52-week high, insider's PETS trades 0 of 2 well-timed at 90-day mark.

NINA CAPITAL HOLDINGS acquired 25,000 shares at $3.94 on 2025-06-03, increasing holdings to 2,550,000 shares. This is the insider's sixth transaction in PETS within four months, following buys on 2025-05-21, 2025-03-18, 2025-03-10, 2025-03-03, and 2025-02-03. The repeated accumulation at depressed levels (current price $3.94 is -40.3% from the 52-week high of $6.60) continues a pattern, though measurable outcomes from prior PETS transactions are poor: the two prior trades with complete 90-day data showed negative 90-day returns (-14.4% and -24.9%), and neither trade proved well-timed. The underlying business remains structurally challenged: PetMed Express posted net income of $-707,000.00 over the most recent quarter and was unprofitable over its most recent full fiscal year, limiting the fundamental case for conviction despite the insider's continued accumulation at attractive price levels.

10% owner NINA CAPITAL HOLDINGS buys 25,000 shares at $3.86; stock down -45.2% from 52-week high, insider's prior PETS trades all negative at 90d

NINA CAPITAL HOLDINGS acquired 25,000 shares (1.0% increase) of PETMED EXPRESS at $3.86 on 2025-05-21, holding 2,525,000 shares post-transaction. The timing is notable: at $3.86, the purchase was well below the 52-week high of $6.60, and the stock has since declined further to $3.62 (current price, -45.2% from peak). However, the insider's track record at this specific ticker is concerning—all 5 prior trades at PETS show negative 90-day returns, including -24.9%, -24.5%, and three recent trades with immeasurable 90d outcomes but all negative 30-day returns. Across the insider's broader cross-ticker history, 10 prior open-market buys averaged -7.9% at 30 days and -13.3% at 90 days, with a 90-day win rate of only 14.29%. Fundamentally, PETMED EXPRESS remains unprofitable (net income $-707,000 in the latest quarter) despite modest annual revenue growth of +9.4%, with a compressed P/E of 181.00. The purchase does not contradict the observed pattern of poor subsequent returns on this insider's acquisitions.

10% owner NINA CAPITAL HOLDINGS INC. buys 100,000 shares of PETS at $4.08; stock down 38.2% from 52-week high, company unprofitable.

NINA CAPITAL HOLDINGS INC., a 10% owner, purchased 100,000 shares at $4.08 on 2025-03-18, raising holdings to 2.50M shares from 2.40M shares. This represents the insider's second buy in eight days and third in three weeks at this ticker. The stock is currently trading at -38.2% from its 52-week high of $6.60 and -20.0% over the 90-day period. Fundamentally, PETMED EXPRESS remains unprofitable with negative net income of $-707,000 in the latest quarter despite 9.4% annual revenue growth, and carries a notably elevated P/E of 204.00. Across the insider's prior trades at PETS, the recent pattern shows losses: the 2025-02-03 buy returned -17.0% at 30 days, the 2025-01-27 buy returned -3.1%, and the 2025-01-24 buy returned -11.7%. This accumulation during weakness, combined with unprofitability and an extended valuation multiple, suggests conviction in mean reversion, but prior same-ticker buys at higher prices have not yet recovered.

NINA CAPITAL HOLDINGS (10% owner) bought 100,000 shares of PETS at $4.11, now down to $3.99; stock down 39.6% from 52-week high, company unprofitable.

NINA CAPITAL HOLDINGS, a 10% owner, purchased 100,000 shares at $4.11 on 2025-03-10, increasing holdings to 2,400,000 shares. The transaction occurs as PETS trades down 39.6% from its 52-week high of $6.60 and down 25.0% over the past 30 days. The company is unprofitable with net income of $-707,000 on revenue of $53.0M, and the stock carries a P/E of 199.50, reflecting very limited earnings. NINA's prior trades at PETS show mixed near-term results (ranging from -17.0% to +10.6% over 30 days), and the insider has no measurable 90-day outcomes on this ticker yet to establish a pattern of trade timing.

10% owner NINA CAPITAL HOLDINGS adds 50,000 shares of PETS at $4.32; stock down 40.2% from 52-week high, company unprofitable.

NINA CAPITAL HOLDINGS, a 10% shareholder, purchased 50,000 shares at $4.32 on 2025-03-03, increasing holdings to 2.30M shares. The timing coincides with significant weakness: PETS is down 40.2% from its 52-week high of $6.60 and has declined 17.0% over 30 days and 27.1% over 90 days. At the same-ticker level, NINA's prior four measurable trades at PETS produced mixed results (30-day returns ranging from +10.6% to -11.7%), with none yet resolved at the 90-day horizon. Fundamentally, the company reported net income of $-707.0K against revenue of $53.0M, indicating ongoing unprofitability despite 9.4% annual revenue growth, and trades at a P/E of 197.50. The purchase occurs against a backdrop of depressed share price and operational losses, but no filing flags indicate whether this acquisition is scheduled or discretionary.

NINA CAPITAL HOLDINGS (10% owner) buys 25,000 PETS shares at $4.82; now holds 2,250,000 shares after recent string of PETS acquisitions

NINA CAPITAL HOLDINGS acquired 25,000 shares of PETMED EXPRESS at $4.82 on 2025-02-03, adding to 2,225,000 pre-transaction holdings for a +1.1% increase. This purchase is the fifth acquisition by this 10% owner at PETS within the past two months (also buying on 2025-01-27, 2025-01-24, 2025-01-07, and 2024-12-16), indicating sustained accumulation despite mixed near-term results on prior same-ticker trades (30-day returns of -9.6% and -14.0% on two earlier purchases). While the company posted revenue of $59,570,000 and net income of $2,326,000 in the latest quarter, it remains unprofitable on a full-year basis, introducing financial context to the repeated buying activity. The current stock price of $4.91 sits 25.6% below the 52-week high and only 1.9% above the transaction price, offering limited near-term validation of the entry point.

NINA Capital Holdings (10% owner) acquired 50,000 PETS shares in 2 tranches for $239,550 at avg $4.79; blended price 1.5% above current $4.72.

NINA Capital Holdings, a 10% shareholder, made 2 separate purchases totaling 50,000 shares for $239,550.00, expanding its stake from 2,175,000 to 2,225,000 shares (+2.3%). The blended average purchase price of $4.79 sits modestly above the current price of $4.72, placing the transaction in slightly underwater territory. PETS is unprofitable on a full-year basis despite recent quarterly net income of $2,326,000.00 and annual revenue growth of +9.4%, suggesting the stock remains in turnaround mode. At the SAME-TICKER HISTORY level, NINA's prior buy on 2024-09-09 achieved a +72.2% 90-day return, but the more recent purchases on 2024-12-06 and 2024-12-16 are down -14.0% and -9.6% respectively (30-day windows), indicating deteriorating near-term outcomes at this specific ticker despite a 100% cross-ticker win rate overall.

10% owner NINA CAPITAL bought 25,000 shares of PETS at $4.98 on Jan 7; stock now down 20.9% in 30 days

NINA CAPITAL, a 10% owner of PetMed Express, purchased 25,000 shares at $4.98 on 2025-01-07, increasing holdings to 2.18M shares from 2.15M shares. This represents the insider's third discretionary buy in the last two months at PETS. The stock has declined 20.9% over the past 30 days and currently trades at $4.77, below the transaction price. At the same-ticker level, the insider's prior buy on 2024-09-09 at PETS generated +72.2% return over 90 days, but recent purchases on 2024-12-06 and 2024-12-16 have not yet demonstrated measurable long-term outcomes. The company reported positive quarterly net income ($2.3M) but remains unprofitable on a full-year basis, creating uncertainty about sustainable profitability. The rapid sequence of buys within a tight price window warrants monitoring of whether the insider's conviction materializes or if near-term headwinds reverse.